Navigation Links
Waters Corporation and UCLA to Convene Leading Life Scientists
Date:9/3/2010

MILFORD, Mass., Sept. 3 /PRNewswire/ -- Waters Corporation (NYSE: WAT) and the University of California at Los Angeles (UCLA) will bring together some of the world's leading life science researchers and practitioners of mass spectrometry (MS) at a conference next month to discuss the ways they are applying time-of-flight mass spectrometry to complex biomolecule research and analysis. Waters today announced the agenda and presentation topics for the Applications of Time of Flight Mass Spectrometry Conference, which will held at The Queen Mary in Long Beach, California, from September 13-15.

"This meeting provides an excellent platform for review and discussion of the most current theories and applications in time-of-flight mass spectrometry," said Brian Smith, V.P. Mass Spectrometry Operations, Waters Division.  "The conference will bring together leaders with specialties in areas such as proteomics, chemistry and pharmacology, all of whom are gathering to share ideas and advance research."

Meeting attendees and presenters hail from some of the most prestigious academic and industrial laboratories.  Twenty-five presentations will be given on topics such as quantitative proteomics, drug discovery, probing protein conformation, protein complexes, metabolites, lipids and glycoproteins.

Waters scientists are presenting at the Applications of Time of Flight Mass Spectrometry Conference.  Copies of their presentations will be available for downloading from the Waters website shortly after the meeting concludes.

  • Practical and Theoretical Constraints upon System-wide Protein Quantification by LC-MS , James Langridge
  • Characterization of Protein Therapeutics by Ion-mobility Time-of-flight Mass Spectrometry, Weibin Chen
  • Use of OA Login and OA Toolkit for Walkup Open Access Accurate Mass LC/MS, John Van Antwerp
  • Development of a Lipidomic Platform Based on a Hybrid Quadrupole Time-Of-Flight (QTof) Ion-Mobility Mass Spectrometer for Both Targeted And Non-targeted Analysis, John Shockcor

Waters benchtop and research-grade time-of-flight (Tof) and quadrupole time-of-flight mass spectrometers (QTof) – the Waters Xevo®, Synapt® HDMS mass spectrometers, and LCT Premier™ – are state-of-the-art instruments known for their ability to elucidate the structure of biomolecules – be they individual proteins, protein complexes, protein metabolites, protein biomarkers.  Their ability to make exact mass measurements – pinpointing a molecular ion's mass-to-charge ratio to four decimal places – makes Tof mass spectrometers a favorite for identifying unknown molecules and assigning them a structure.

Recent advances in technology are making Tof mass spectrometers more capable of quantifying proteins in samples enabling scientists to perform qualitative and quantitative experiments in a single analysis, something that was virtually impossible to do a few years ago.

About Waters Corporation (www.waters.com)

For more than 50 years, Waters Corporation creates business advantages for laboratory-dependent organizations by delivering practical and sustainable innovation to enable significant advancements in such areas as healthcare delivery, environmental management, food safety, and water quality worldwide.

Pioneering a connected portfolio of separations science, laboratory information management, mass spectrometry and thermal analysis, Waters technology breakthroughs and laboratory solutions provide an enduring platform for customer success.

With revenue of $1.5 billion in 2009 and 5,200 employees, Waters is driving scientific discovery and operational excellence for customers worldwide.

Waters, Xevo, LCT Premier and Synapt are trademarks of Waters Corporation


'/>"/>
SOURCE Waters Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Waters Brings Advanced Laboratory Data Management to Microsofts BioIT Alliance
2. David H. Murdock Research Institute Taps Waters for Laboratory Technology
3. Waters Publishes Rapid and Specific Method of Detection for Melamine in Infant Formula and Liquid Milk, in Support of Chinas Ministry of Science and Technology
4. Waters Corporation Gives Boost to Clinical Research Programs at University of Sherbrooke Hospital
5. Waters New ACQUITY UPLC Online Community Attracts More Than 1,200 Members in First Month
6. XenoTech LLC Offers Drug Industry New Metabolite Profiling Services Following Acquisition of Waters Synapt HDMS System
7. USDA Boosts Food Safety Research with Purchase of Waters ACQUITY TQD System
8. Waters Corporation Continues to Meet Todays Challenges for Improved Laboratory Operations with New Products at Pittcon 2009
9. Waters and University of Warwick Sign Research Agreement Designed to Foster Adoption of Novel MS Technologies
10. Waters Introduces New SYNAPT G2 with Greater Power, Versatility and Speed Than Any Other High-End Mass Spectrometer
11. First ASMS Hites Award for Outstanding Research Publication Presented to Prof. Alison Ashcroft for Her Use of Waters Synapt HDMS System to Explore Protein Complexes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... ... ... In starting a program to hire college athletes, Catalyst COO ... skill.” , In keeping with this philosophy, the Catalyst an Iowa premix manufacturer recently ... to replicate the practice throughout the company. , “I’ve heard coaches talk on television ...
(Date:2/25/2017)... ... February 25, 2017 , ... The ... in an ongoing effort to create meaningful change by increasing communication, partnerships and ... emphasis on consumers and patients’ mental health well-being. , Both organizations are dedicated ...
(Date:2/24/2017)... San Diego, Calif. (PRWEB) , ... February 24, 2017 , ... ... African food and wine scene. Making stops in several cities, she gained a ... Her culinary adventure began in Stellenbosch, a town in South Africa’s Western Cape province. ...
(Date:2/24/2017)... Feb. 24, 2017 Symic Bio, a biopharmaceutical ... new category of therapeutics, announced today the completion of ... peripheral artery disease. The trial will evaluate the safety ... in the reduction of restenosis following angioplasty. ... milestone for SB-030," said Nathan Bachtell , M.D., ...
Breaking Biology Technology:
(Date:2/10/2017)... , Feb 10, 2017 Research ... report "Personalized Medicine - Scientific and Commercial Aspects" ... ... medicine. Diagnosis is integrated with therapy for selection of treatment ... early detection and prevention of disease in modern medicine. Biochip/microarray ...
(Date:2/8/2017)... Feb. 7, 2017 Report Highlights ... The global synthetic-biology market ... billion by 2021, growing at a compound annual growth rate ... overview of the global markets for synthetic biology. - Analyses ... 2016, and projections of compound annual growth rates (CAGRs) through ...
(Date:2/7/2017)... , Feb. 7, 2017 Zimmer Biomet Holdings, ... musculoskeletal healthcare, will present at the LEERINK Partners 6th ... Palace Hotel on Wednesday, February 15, 2017 at 10 ... of the presentation can be accessed at http://wsw.com/webcast/leerink28/zbh ... the conference via Zimmer Biomet,s Investor Relations website at ...
Breaking Biology News(10 mins):